These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19541676)

  • 1. The impact of ataxin-1-like histidine insertions on polyglutamine aggregation.
    Jayaraman M; Kodali R; Wetzel R
    Protein Eng Des Sel; 2009 Aug; 22(8):469-78. PubMed ID: 19541676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: A molecular approach.
    Sen S; Dash D; Pasha S; Brahmachari SK
    Protein Sci; 2003 May; 12(5):953-62. PubMed ID: 12717018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions.
    Sharma D; Sharma S; Pasha S; Brahmachari SK
    FEBS Lett; 1999 Jul; 456(1):181-5. PubMed ID: 10452554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyglutamine expansion accelerates the dynamics of ataxin-1 and does not result in aggregate formation.
    Krol HA; Krawczyk PM; Bosch KS; Aten JA; Hol EM; Reits EA
    PLoS One; 2008 Jan; 3(1):e1503. PubMed ID: 18231590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathogenesis of spinocerebellar ataxia type 1 disease.
    Kang S; Hong S
    Mol Cells; 2009 Jun; 27(6):621-7. PubMed ID: 19572115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a self-association region within the SCA1 gene product, ataxin-1.
    Burright EN; Davidson JD; Duvick LA; Koshy B; Zoghbi HY; Orr HT
    Hum Mol Genet; 1997 Apr; 6(4):513-8. PubMed ID: 9097953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
    Yue S; Serra HG; Zoghbi HY; Orr HT
    Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaleidoscopic protein-protein interactions in the life and death of ataxin-1: new strategies against protein aggregation.
    de Chiara C; Pastore A
    Trends Neurosci; 2014 Apr; 37(4):211-8. PubMed ID: 24636457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments.
    Jayaraman M; Kodali R; Sahoo B; Thakur AK; Mayasundari A; Mishra R; Peterson CB; Wetzel R
    J Mol Biol; 2012 Feb; 415(5):881-99. PubMed ID: 22178474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro.
    Calabresi V; Guida S; Servadio A; Jodice C
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):337-42. PubMed ID: 11719269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-hairpin-mediated nucleation of polyglutamine amyloid formation.
    Kar K; Hoop CL; Drombosky KW; Baker MA; Kodali R; Arduini I; van der Wel PC; Horne WS; Wetzel R
    J Mol Biol; 2013 Apr; 425(7):1183-97. PubMed ID: 23353826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational behavior and aggregation of ataxin-3 in SDS.
    Saunders HM; Hughes VA; Cappai R; Bottomley SP
    PLoS One; 2013; 8(7):e69416. PubMed ID: 23894474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxin-1 fusion partners alter polyQ lethality and aggregation.
    Rich T; Varadaraj A
    PLoS One; 2007 Oct; 2(10):e1014. PubMed ID: 17925862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.
    Klement IA; Skinner PJ; Kaytor MD; Yi H; Hersch SM; Clark HB; Zoghbi HY; Orr HT
    Cell; 1998 Oct; 95(1):41-53. PubMed ID: 9778246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human proteins that modify misfolding and proteotoxicity of pathogenic ataxin-1.
    Petrakis S; Raskó T; Russ J; Friedrich RP; Stroedicke M; Riechers SP; Muehlenberg K; Möller A; Reinhardt A; Vinayagam A; Schaefer MH; Boutros M; Tricoire H; Andrade-Navarro MA; Wanker EE
    PLoS Genet; 2012; 8(8):e1002897. PubMed ID: 22916034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
    Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
    Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tissue transglutaminase type 2 in calbindin-D28k interaction with ataxin-1.
    Vig PJ; Wei J; Shao Q; Hebert MD; Subramony SH; Sutton LT
    Neurosci Lett; 2007 Jun; 420(1):53-7. PubMed ID: 17442486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between aggregation and toxicity of polyglutamine-containing ataxin-3 in the intracellular environment of Escherichia coli.
    Invernizzi G; Aprile FA; Natalello A; Ghisleni A; Penco A; Relini A; Doglia SM; Tortora P; Regonesi ME
    PLoS One; 2012; 7(12):e51890. PubMed ID: 23251648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences.
    Lakhani VV; Ding F; Dokholyan NV
    PLoS Comput Biol; 2010 Apr; 6(4):e1000772. PubMed ID: 20442863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.